Genomictree지노믹트리
228760 · KOSDAQ · ₩228760 · 지노믹트리
₩9,900▼ ₩500 (4.81%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | −5.0% | 19.0% | −30.8% | −7.9% | 83.7% | 48.9% |
| Operating margin | −398.4% | −300.5% | −648.2% | −506.2% | 8.1% | −191.7% |
| Net margin | −306.4% | −239.0% | −433.6% | −256.2% | −22.2% | −222.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −21.6% | +59.2% | −30.9% | −88.6% | +481.1% | — |
| Operating income growth | −3.9% | +26.2% | +11.5% | −819.4% | +124.4% | — |
| Net income growth | −0.5% | +12.3% | −17.0% | −32.1% | +42.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −7.6% | −7.5% | −8.2% | −7.6% | −6.0% | −9.9% |
| Return on assets | −7.5% | −7.3% | −7.9% | −6.1% | −3.9% | −6.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 2.0% | 4.7% | 5.1% | 6.2% | 51.5% | 53.9% |
| Net debt to equity | −64.9% | −65.1% | −75.7% | −73.1% | −35.8% | −25.4% |
| Current ratio | 6,084.8% | 1,775.3% | 2,055.7% | 1,805.8% | 220.8% | 6,270.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Genomictree / 지노믹트리 / 228760 / KRX:228760
Source: KRX statistical information